The Austrian brain tumour registry: a cooperative way to establish a population-based brain tumour registry, J Neurooncol, vol.95, issue.3, pp.401-411, 2009. ,
CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in, Neuro Oncol, vol.16, pp.1-63, 2007. ,
WHO Classification of Tumors of th Central Nervous System, 2007. ,
Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma, J Neurooncol, vol.107, issue.2, pp.315-321, 2012. ,
Temozolomide for treatment-resistant recurrent meningioma, Neurology, vol.13, issue.7, pp.1210-1212, 2004. ,
Salvage chemotherapy with CPT-11 for recurrent meningioma, J Neurooncol, vol.78, issue.3, pp.271-276, 2006. ,
Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas, Cancer, vol.15, issue.8, pp.2146-2151, 2008. ,
Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma, Cancer Invest, vol.24, issue.8, pp.727-733, 2006. ,
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma, Neuro Oncol, vol.13, issue.5, pp.530-535, 2011. ,
Lack of efficacy of megestrol acetate in the treatment of unresectable meningioma, J Neurooncol, vol.8, issue.1, pp.61-65, 1990. ,
Atypical and anaplastic meningiomas treated with bevacizumab, J Neurooncol, vol.109, issue.1, pp.187-193, 2012. ,
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08), Neuro Oncol, vol.11, issue.6, pp.853-860, 2009. ,
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma, J Neurooncol, vol.96, issue.2, pp.211-217, 2010. ,
Historical benchmarks for medical therapy trials in surgery-and radiation-refractory meningioma: A RANO review, Neuro Oncol, vol.16, issue.6, pp.829-840, 2014. ,
Improving lesion-symptom mapping, J Cogn Neurosci, vol.19, issue.7, pp.1081-1088, 2007. ,
Recurrent meningioma: salvage therapy with long-acting somatostatin analogue, Neurology, vol.69, issue.10, pp.969-973, 2007. ,
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas, J Neurooncol, vol.117, issue.1, pp.93-101, 2014. ,
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma, Neuro Oncol, vol.17, issue.1, pp.116-121, 2015. ,
Bevacizumab-induced regression of anaplastic meningioma, Ann Oncol, vol.21, issue.12, pp.2445-2446, 2010. ,
Expression of vascular endothelial growth factor (VEGF) and its receptors VEGFR1 and VEGFR2 in primary and recurrent WHO grade III meningiomas, Histol Histopathol, vol.28, issue.9, pp.1157-1166, 2013. ,
Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches, Clin Neuropathol, vol.31, issue.5, pp.352-360, 2012. ,
Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation, Ann Oncol, vol.21, issue.11, p.2294, 2010. ,
Peritumoral brain edema in angiomatous supratentorial meningiomas: an investigation of the vascular endothelial growth factor A pathway, APMIS, vol.121, issue.11, pp.1025-1036, 2013. ,
Role of VEGF and matrix metalloproteinase-9 in peritumoral brain edema associated with supratentorial benign meningiomas, Neuropathology, vol.32, issue.6, pp.638-646, 2012. ,
Vascular endothelial growth factor: the major factor for tumor neovascularization and edema formation in meningioma patients, Neurosurgery, vol.67, issue.6, pp.1703-1708, 2010. ,
Systemic therapy of malignant meningioma ,